ARCHIVES

In Brief: FDA Stops Imports Of Counterfeit Adriamychin; Rosenburg: NIH Pay 25-33% That Of Academia

This article is from The Cancer Letter archive.

Vol. 14 No. 17 | April 22, 1988

Download PDF Visit The Full Archive

Related Articles

PV-10 Produces 51 Percent Response Rate in Phase II Trial

October 26, 2012

In Brief: Bristol Has Change Of Heart, Agrees To Supply NCI With VP-16 Free For Group C Distribution

July 16, 1982

Smokeless Tobacco Consensus Conference Slates in Health Risks

August 16, 1985

Age Shouldn’t Determine Lung Cancer Treatment, ASCO Says In New Guideline

November 27, 2009

Senate Subcommittee Votes $970 Million for NCI In FY 1980; Magnuson Cancer Support Holds Firm

June 23, 1978

In Brief: Blumberg to direct NASA Astrobiology Institute’ Hopkins To Get $20M Donation

May 28, 1999